Title : The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer's disease.

Pub. Date : 2012 Sep 15

PMID : 22360429






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AIMS: The aim of the present study was to evaluate the therapeutic effect of the novel neuroprotective multi-target nontoxic, lipophilic, brain permeable monoamine oxidase inhibitor and iron chelating-radical scavenging drug, M30, on the neuropathology and deficits of spatial learning and memory in amyloid precursor protein (APP) and presenilin 1 (PS1) double-transgenic (Tg) Alzheimer"s disease (AD) mice. Iron amyloid beta (A4) precursor protein Mus musculus
2 Here, for the first time, we demonstrated that, when systemically administered to APP/PS1 Tg mice, our novel multifunctional iron chelating/radical scavenging compound, M30, effectively reduced Abeta accumulation and tau phosphorylation, and attenuated memory deficits. Iron amyloid beta (A4) precursor protein Mus musculus